Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
Wrenger
Eike
E
Division of Nephrology, Department of Internal Medicine, Otto-von-Guericke-University, Leipziger Strasse 44, D-39120 Magdeburg, Germany. Eike.Wrenger@medizin.unimagdeburg.de
Müller
Regina
R
Moesenthin
Michael
M
Welte
Tobias
T
Frölich
Jürgen C
JC
Neumann
Klaus H
KH
D058186:Acute Kidney Injury / Q000139:chemically induced; D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects*; D004232:Diuretics / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects*
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D013148:Spironolactone